Program
calcipotriene
Also written as “LEO 90100”, “MC2-01 cream” and “Calcipotriol plus betamethasone dipropionate (LEO80185 gel)”.
Its studies are mostly in Psoriasis · Alopecia Areata, led by 10 companies.
Drug pageCalcipotriene: every studyMany companies study it; this page follows only the 37 they lead. All 70 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| LEO Pharma | 220 open or running | phase 4since Sep 15, 2005 | Sep 15, 2005 | none ahead |
| MC2 Therapeuticsits history only | 50 open or running | phase 3since Oct 9, 2017 | Oct 9, 2017 | none ahead |
| Almirallits history only | 20 open or running | phase 3since Nov 11, 2015 | Nov 11, 2015 | none ahead |
| Mayne Pharma International Ptyits history only | 20 open or running | phase 1since Mar 15, 2012 | Mar 15, 2012 | none ahead |
| Abbottits history only | 10 open or running | phase 3since Dec 12, 2007 | Dec 12, 2007 | none ahead |
| Egymedicalpediaits history only | 10 open or running | no phasesince Jun 23, 2023 | Jun 23, 2023 | none ahead |
| GlaxoSmithKlineits history only | 10 open or running | phase 3since Jun 6, 2010 | Jun 6, 2010 | none ahead |
| Glenmark Pharmaceuticals Ltd. Indiaits history only | 10 open or running | phase 3since Nov 1, 2017 | Nov 1, 2017 | none ahead |
| Huadong Medicineits history only | 10 open or running | phase 3since Dec 11, 2025 | Dec 11, 2025 | none ahead |
| Tolmarits history only | 10 open or running | phase 1since Apr 6, 2017 | Apr 6, 2017 | none ahead |
Also a collaborator on its studies: Bioskin.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of LEO Pharma only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 7 studies since Sep 15, 2005.
- Jan 17, 2006Phase 3 study in PsoriasisNCT00279162 · 160 enrolled · United States
- Mar 18, 2008Phase 3 study in Psoriasis VulgarisNCT00640822 · 782 enrolled · Canada, France, United Kingdom
- Apr 29, 2008Phase 3 study in Psoriasis VulgarisNCT00670241 · 458 enrolled · Canada
- Jun 3, 2008Phase 3 study in Psoriasis VulgarisNCT00691002 · 1,245 enrolled · Croatia, Germany, Poland and more
- Jun 23, 2008Phase 2 study in Psoriasis VulgarisNCT00704262 · 33 enrolled · United States, Canada, Germany and more
- Jan 5, 2009Phase 2 study in Psoriasis VulgarisNCT00817219 · 33 enrolled · United States
- Aug 25, 2010Phase 3 study in Psoriasis VulgarisNCT01188928 · 1,152 enrolled · United States
- Feb 16, 20122 phase 2 studies in Psoriasis VulgarisNCT01536938, NCT01536886
- May 8, 2012Phase 2 study in Psoriasis VulgarisNCT01600222 · 37 enrolled · Canada
- May 28, 2013Phase 3 study in Psoriasis VulgarisNCT01866163 · 426 enrolled · United States
- Aug 27, 2013Phase 1 study in Psoriasis VulgarisNCT01935869 · 224 enrolled · France
- Mar 12, 2015Phase 2 study in Psoriasis VulgarisNCT02387853 · 117 enrolled · United States, Netherlands, Poland and more
- Mar 29, 2019Phase 1 study in Psoriasis VulgarisNCT03898583 · 15 enrolled · Germany
- Jun 16, 2023Phase 3 study in Stable Plaque PsoriasisNCT05919082 · 604 enrolled · China
TargetBeta
“Vitamin D receptor agonist”ChEMBL 37, by rule
Other programs on VDR
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| Modified-release Calcifediol Capsulerule | OPKO Health | phase 3 | 10 |
Studies
All 22 LEO Pharma leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT05919082Stable Plaque Psoriasis · China | 3 | Completed | Feb 23, 2024 | 604 |
| NCT03898583Psoriasis Vulgaris · Germany | 1 | Completed | Oct 29, 2019 | 15 |
| NCT02387853Psoriasis Vulgaris · United States, Netherlands, Poland and more | 2 | Completed | Mar 28, 2018 | 117 |
| NCT01935869Psoriasis Vulgaris · France | 1 | Completed | Nov 2013 | 224 |
| NCT01866163Psoriasis Vulgaris · United States | 3 | Completed | Oct 2013 | 426 |
| NCT01600222Psoriasis Vulgaris · Canada | 2 | Completed | May 2013 | 37 |
| NCT01536938Psoriasis Vulgaris · United States | 2 | Completed | Sep 2012 | 303 |
| NCT01536886Psoriasis Vulgaris · United States | 2 | Completed | Sep 2012 | 376 |
| NCT01188928Psoriasis Vulgaris · United States | 3 | Completed | Mar 2011 | 1,152 |
| NCT00817219Psoriasis Vulgaris · United States | 2 | Completed | Dec 2011 | 33 |
| NCT00704262Psoriasis Vulgaris · United States, Canada, Germany and more | 2 | Completed | Dec 2009 | 33 |
| NCT00691002Psoriasis Vulgaris · Croatia, Germany, Poland and more | 3 | Completed | Jan 2010 | 1,245 |
| NCT00670241Psoriasis Vulgaris · Canada | 3 | Completed | Feb 2009 | 458 |
| NCT00640822Psoriasis Vulgaris · Canada, France, United Kingdom | 3 | Completed | Jun 2009 | 782 |
| NCT00279162Psoriasis · United States | 3 | Completed | 160 | |
| NCT00263718Psoriasis Vulgaris · Canada, Germany, Ireland and more | 2 | Completed | 360 | |
| NCT00248456Psoriasis Vulgaris · China | 4 | Completed | 320 | |
| NCT00243464Psoriasis of Scalp · Belgium, Canada, Denmark and more | 3 | Completed | 300 | |
| NCT00216892Psoriasis Vulgaris · Belgium, Canada, France and more | 4 | Completed | 1,032 | |
| NCT00216879Psoriasis of Scalp · Canada, Denmark, France and more | 3 | Completed | 800 | |
| NCT00216840Psoriasis of Scalp · Belgium, Canada, Finland and more | 3 | Completed | 1,350 | |
| NCT00216827Psoriasis of Scalp · Canada, Denmark, France and more | 3 | Completed | 1,485 |
How it is read
Names in the registry
- “LEO 90100”, 7 entries
- “MC2-01 cream”, 4 entries
- “Calcipotriol plus betamethasone dipropionate (LEO80185 gel)”, 3 entries
- “Calcipotriol plus hydrocortisone (LEO 80190)”, 2 entries
- “MC2-01 Cream”, 2 entries
Codes read as this program: P3073.
Conditions, from the studies’ own filings
- Psoriasis, 37 studies
- Alopecia Areata, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.